Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Blakey

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Cancer Research|February 15, 1987
Effect of chemical deglycosylation of ricin A chain on the in vivo fate and cytotoxic activity of an immunotoxin composed of ricin A chain and anti-Thy 1.1 antibodyD C Blakey, G J Watson, P P Knowles, et al.
Progress in Allergy|January 1, 1988
Antibody toxin conjugates: a perspectiveD C Blakey, E J Wawrzynczak, P M Wallace, et al.
The Biochemical Journal|June 1, 1986
Factors responsible for the formation of different N-alkylated porphyrins in rat liver microsomal systems exposed to norethindrone. The role of 3 alpha-hydroxysteroid dehydrogenaseI N White, D C Blakey, M L Green, et al.
Anticancer Research|November 1, 1993
The interactions of protein inhibitors with tumour proteases studied in solution and immobilised on cell surfaces in frozen sectionsF S Steven, M Anees, I C Talbot, et al.
Biochimica Et Biophysica Acta|January 20, 1987
The preparation of deglycosylated ricin by recombination of glycosidase-treated A- and B-chains: effects of deglycosylation on toxicity and in vivo distributionB M Foxwell, D C Blakey, A N Brown, et al.
Anticancer Research|November 1, 1992
Further evidence for different isoenzymic forms of a cell surface protease, guanidinobenzoatase, associated with tumoursF S Steven, M M Griffin, D C Blakey, et al.
British Journal of Cancer|September 5, 2001
Induction of apoptosis by the ADEPT agent ZD2767: comparison with the classical nitrogen mustard chlorambucil and a monofunctional ZD2767 analogueN R Monks, D C Blakey, N J Curtin, et al.
Biomedical Peptides, Proteins & Nucleic Acids : Structure, Synthesis & Biological Activity|January 1, 1995
In vitro and in vivo comparison of a randomly coupled antibody fragment-enzyme conjugate with a site-specific conjugateR C Werlen, R E Offord, D C Blakey, et al.
British Journal of Cancer|July 20, 2000
Cellular glutathione as a determinant of the sensitivity of colorectal tumour cell-lines to ZD2767 antibody-directed enzyme prodrug therapy (ADEPT)N R Monks, J A Calvete, N J Curtin, et al.
The Journal of Biological Chemistry|April 25, 1986
Purification of ricin A1, A2, and B chains and characterization of their toxicityR J Fulton, D C Blakey, P P Knowles, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Cancer Research|February 15, 1987
Effect of chemical deglycosylation of ricin A chain on the in vivo fate and cytotoxic activity of an immunotoxin composed of ricin A chain and anti-Thy 1.1 antibodyD C Blakey, G J Watson, P P Knowles, et al.
Progress in Allergy|January 1, 1988
Antibody toxin conjugates: a perspectiveD C Blakey, E J Wawrzynczak, P M Wallace, et al.
The Biochemical Journal|June 1, 1986
Factors responsible for the formation of different N-alkylated porphyrins in rat liver microsomal systems exposed to norethindrone. The role of 3 alpha-hydroxysteroid dehydrogenaseI N White, D C Blakey, M L Green, et al.
Anticancer Research|November 1, 1993
The interactions of protein inhibitors with tumour proteases studied in solution and immobilised on cell surfaces in frozen sectionsF S Steven, M Anees, I C Talbot, et al.
Biochimica Et Biophysica Acta|January 20, 1987
The preparation of deglycosylated ricin by recombination of glycosidase-treated A- and B-chains: effects of deglycosylation on toxicity and in vivo distributionB M Foxwell, D C Blakey, A N Brown, et al.
Anticancer Research|November 1, 1992
Further evidence for different isoenzymic forms of a cell surface protease, guanidinobenzoatase, associated with tumoursF S Steven, M M Griffin, D C Blakey, et al.
British Journal of Cancer|September 5, 2001
Induction of apoptosis by the ADEPT agent ZD2767: comparison with the classical nitrogen mustard chlorambucil and a monofunctional ZD2767 analogueN R Monks, D C Blakey, N J Curtin, et al.
Biomedical Peptides, Proteins & Nucleic Acids : Structure, Synthesis & Biological Activity|January 1, 1995
In vitro and in vivo comparison of a randomly coupled antibody fragment-enzyme conjugate with a site-specific conjugateR C Werlen, R E Offord, D C Blakey, et al.
British Journal of Cancer|July 20, 2000
Cellular glutathione as a determinant of the sensitivity of colorectal tumour cell-lines to ZD2767 antibody-directed enzyme prodrug therapy (ADEPT)N R Monks, J A Calvete, N J Curtin, et al.
The Journal of Biological Chemistry|April 25, 1986
Purification of ricin A1, A2, and B chains and characterization of their toxicityR J Fulton, D C Blakey, P P Knowles, et al.
Pageof 4